US identifies patients at higher stroke risk
Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.
Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.
The technique might also be useful in selecting patients with asymptomatic carotid stenosis who are likely to benefit from endarterectomy.
Embolic signs-short-duration, high-energy signals-were present in 77 of 467 patients at baseline. The hazard ratio for the risk of ipsilateral stroke and transient ischemic attack from baseline to two years in patients with embolic signals compared with those without was 2.54. The hazard ratio for ipsilateral stroke alone was 5.57 (Lancet DOI:10.1016/S1474-4422(10)70120-4).
Absolute annual risk of ipsilateral stroke or a transient ischemic attack between baseline and two years was 7.13% in patients with embolic signals and 3.04% in those without. The absolute annual risk of ipsilateral stroke alone was 3.62% in patients with embolic signals and 0.7% in those without.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
